10-Q: Safety Shot Inc. Reports Q1 2025 Financial Results, Revenue Declines Amid Strategic Shift

Safety Shot Inc. reports a decrease in revenue for Q1 2025, attributing it to a strategic focus on the acquisition of Yerbae Brands Inc. and a new marketing strategy set to launch in Q2 2025.

Summary

• Safety Shot Inc. reported a net loss of $5.33 million for the three months ended March 31, 2025, compared to a net loss of $15.67 million for the same period in 2024.
• Revenue decreased to $42,101 from $170,732 year-over-year, which the company attributes to a strategic shift towards the acquisition of Yerbae Brands Inc. and a new marketing strategy planned for Q2 2025.
• Operating expenses totaled $5.41 million, including marketing expenses of $356,430, research and development expenses of $9,005, and legal and professional fees of $2.15 million.
• The company issued 1,570,000 shares of restricted common stock for services valued at $1,715,500 and 9,038,650 unrestricted shares in private placements for $4,971,971.
• Safety Shot settled litigation with Bigger Capital, agreeing to pay $375,000, issue convertible notes, and issue warrants.
• The company is pursuing a liabilities settlement program with Silverback Capital Corporation to pay down debts in exchange for issuing freely trading securities.
• As of March 31, 2025, the company had cash of $329,285 and an accumulated deficit of $120,417,280, raising substantial doubt about its ability to continue as a going concern.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the net loss has decreased, revenue is down significantly, and there are concerns about the company's ability to continue as a going concern. The potential dilution from the liabilities settlement program is also a negative factor.

Positives

• The net loss decreased significantly from $15.67 million in Q1 2024 to $5.33 million in Q1 2025.
• The company is implementing a new marketing strategy in Q2 2025, which may improve revenue.
• Settlement of litigation with Bigger Capital removes a significant legal overhang.
• The company is actively pursuing a liabilities settlement program to reduce its debt.

Negatives

• Revenue decreased significantly from $170,732 in Q1 2024 to $42,101 in Q1 2025.
• The company has a substantial accumulated deficit of $120,417,280.
• Auditors have expressed doubt about the company's ability to continue as a going concern.
• The company is relying on a liabilities settlement program that involves issuing a significant number of shares, potentially diluting existing shareholders.

Risks

• The company's ability to continue as a going concern is uncertain due to its accumulated deficit and limited cash reserves.
• The new marketing strategy may not be successful in increasing revenue.
• The liabilities settlement program could significantly dilute existing shareholders.
• The company is subject to government regulations, and unfavorable changes could substantially harm its business and results of operations.
• The company relies on third parties for manufacturing and clinical trials, which could lead to delays or quality issues.

Future Outlook

The company is focusing on the acquisition of Yerbae Brands Inc. and plans to implement a new marketing strategy in Q2 2025. The company is also advancing several product formats and formulations to continue to offer a wide array of products that can be purchased at various locations that coincide with consumer shopping habits.

Management Comments

• The decrease in revenue is due to the Company redirecting its focus on the acquisition of Yerbae Brands Inc. and the Companys new marketing strategy will be implemented in the 2nd quarter of 2025.

Industry Context

The company operates in the competitive dietary supplement market, facing competition from established brands and new entrants. The company's focus on innovation and clinical research is intended to differentiate its products.

Comparison to Industry Standards

• It is difficult to compare Safety Shot's results directly to industry standards due to its unique product and early stage of commercialization.
• Comparable companies in the beverage and dietary supplement space include Celsius Holdings, Inc. (CELH) and Nutraceutical International Corporation (NUTR), but their product lines and market positions differ significantly.
• Celsius has shown strong revenue growth in recent years, driven by its energy drink products, while Nutraceutical International focuses on a broader range of dietary supplements.
• Safety Shot's Q1 2025 revenue decline contrasts with the growth trends seen in some segments of the beverage and supplement industry, highlighting the challenges of launching a new product and executing a strategic shift.

Legal Proceedings

• The company is involved in several legal proceedings, including lawsuits filed by Intracoastal Capital, Sabby Volatility Warrant Master Fund Ltd., 3i LP, Bigger Capital fund, L.P., and Alta Partners, LLC.
• The company has settled litigation with Bigger Capital and Alta Partners, LLC.

Stakeholder Impact

• Shareholders may experience dilution due to the potential issuance of shares in the liabilities settlement program.
• Employees' job security may be affected by the company's financial challenges.
• Customers may be impacted by changes in product availability or marketing strategies.
• Creditors face increased risk due to the company's going concern issues.

Next Steps

• Implement the new marketing strategy in Q2 2025.
• Continue to pursue the acquisition of Yerbae Brands Inc.
• Secure additional financing to address going concern issues.
• Monitor the progress of the liabilities settlement program.

Key Dates

Keywords

Safety Shot, financial results, Q1 2025, Yerbae Brands, acquisition, revenue, net loss, litigation, convertible notes, warrants, going concern, dietary supplement